Abstract
Earlier neurochemical studies suggested that human brain carboxypeptidase B may play a significant role in the degradation of amyloid-β1-42 in the brain. Using an immunohistochemical technique we report here on the neuronal expression and distribution of this enzyme in the segments (CA1a, CA1b and CA1c) of the CA1 subfield and in area CA4 of the hippocampus in normal and Alzheimer’s disease brain samples. Its distribution was compared with the appearance of neurofibrillary tangles in the same brain sample. For immunohistochemical localization of carboxypeptidase B, a specific C14-module antibody was applied, together with the Gallyas silver impregnation technique for the demonstration of neurofibrillary tangles. The results revealed that, in the control samples, most of the immunoreactivity appeared in segment CA1a in the pyramidal cells, less in segment CA1b and least in segment CA1c. In the Alzheimer’s disease samples, there was no particular immunostaining in the neurons, but, a large number of silver-impregnated degenerated neurons appeared. The results support the suggestion that carboxypeptidase B may play a significant role in elimination of the intracellular accumulation and toxicity of amyloid-β in the human brain and thereby protect the neurons from degeneration.
Article PDF
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
References
Akiyama, H., Kondo, H., Ikeda, K., Kato, M., McGeer, P. L. (2001) Immunohistochemical localization of neprilysin in the human cerebral cortex: inverse association with vulnerability to amyloid β-protein (Aβ) deposition. Brain Res. 902, 77–281.
Bobinski, M., Wegiel, J., Wisniewski, H. M., Tarnawski, M., Bobinski, M., Reisberg, B., De Leon, M. J., Miller, D. C. (1996) Neurofibrillary pathology - Correlation with hippocampal formation atrophy in Alzheimer disease. Neurobiol. Aging 17, 909–919.
Braak, H., Braak, E. (1998) Evolution of neuronal changes in the course of Alzheimer’s disease. J. Neural. Transm. 53, 127–140.
Brady, D. R., Mufson, E. J. (1991) Alz-50 immunoreactive neurophil differentiates hippocampal complex subfields in Alzheimer’s disease. J. Comp. Neurol. 305, 489–507.
Fukutani, Y., Kobayashi, K., Nakamura, I., Watanabe, K., Isaki, K., Cairns, N. J. (1995) Neurons, intracellular and extracellular neurofibrillary tangles in subdivisions of the hippocampal cortex in normal ageing and Alzheimer’s disease. Neurosci. Lett. 200, 57–60.
Gallyas, F. (1971) Silver staining of Alzheimer’s neurofibrillary changes by means of physical development. Acta Morphol. Acad Sci. Hung. 19, 1–8.
Haga, C., Ikeda, K., Iwabuchi, K., Akiyama, H., Kondoh, H., Kosaka, K. (1994) Methenamine-sil-ver staining: a simple and sensitive staining method for senile plaques and neurofibrillary tangles. Biotechnic Histochem. 69, 295–300.
Iqbal, K., Alonso, A. C., Gong, C. X., Khatoon, S., Pei, J. J., Wang, J. Z., Grundke-Iqbal, I. (1998) Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles. J. Neural. Transm. Suppl. 53, 169–180.
Iwata, N., Tsubuki, S., Takaki, Y., Watanabe, K., Sekiguchi, M., Hosoki, E., Kawashima-Morishima, M., Lee, H. J., Hama, E., Sekine-Aizawa, Y., Saido, T. C. (2000) Identification of the major Aβ1-42-degrading catabolic pathway in brain parenchyma: Suppression leads to biochemical and pathological deposition. Nat. Med. 6, 143–150.
Iwata, N., Tsubuki, S., Takaki, Y., Shirotani, K., Lu, B., Gerard, C., Hama, E., Lee, H. J., Saido, T. C. (2001) Metabolic regulation of brain Aβ by neprilysin. Science 292, 1550–1552.
Kása, P., Papp, H., Kása, P. jr, Török, I. (2000) Donepezil dose-dependently inhibit acetyl-cholinesterase activity in various areas and in the presynaptic cholinergic and the postsynaptic cholinoceptive enzyme-positive structures in the human and rat brain. Neuroscience 1001, 89–100.
Kása, P., Rakonczay, Z., Gulya, K. (1997) The cholinergic system in Alzheimer’s disease. Prog. Neurobiol. 52, 511–535.
Markesbery, W. R. (1997) Neuropathological criteria for the diagnosis of Alzheimer’s disease. Neurobiol. Aging 18, S13-S19.
Matsumoto, A., Itoh, K., Matsumoto, R. (2000) A novel carboxypeptidase B that processes native β-amyloid precursor protein is present in human hippocampus. Eur. J. Neurosci. 12, 227–238.
Matsumoto, A., Itoh, K., Seki, T., Motozaki, K., Matsuyama, S. (2001) Human brain carboxypepti-dase B, which cleaves β-amyloid peptides in vitro is expressed in the endoplasmic reticulum of neurons. Eur. J. Neurosci. 13, 1653–1657.
Matsumoto, A., Motozaki, K., Seki T., Sasaki, R., Kawabe, T. (2001) Expression of human brain car-boxypeptidase B, a possible cleaving enzyme for β-amyloid precursor protein, in peripheral fluids. Neurosci. Res. 39, 313–317.
Nakamura, Y., Takeda, M., Suzuki, H., Hattori, H., Tada, K., Hariguchi, S., Hashimoto, S., Nishimura, T. (1991) Abnormal distribution of cathepsins in the brain of patients with Alzheimer’s disease. Neurosci. Lett. 130, 195–198.
Shirotani, K., Tsubuki, S., Iwata, N., Takaki, Y., Harigaya, W., Maruyama, K., Kiryu-Seo, S., Kiyama, H., Iwata, H., Tomita, T., Iwatsubo, T., Saido, T. C. (2001) Neprilysin degrades both amyloid beta peptides 1-40 and 1-42 most rapidly and efficiently among thiorphan- and phosphoramidon-sensitive endopeptidases. J. Biol. Chem. 276, 21895–21901.
Yamaguchi, H., Haga, C., Hirai, S., Nakazato, Y., Kosaka, K. (1990) Distinctive, rapid, and easy labeling of diffuse plaques in the Alzheimer brain by new methenamine silver stain. Acta Neuropathol. 79, 569–572.
Yasojima, K., McGeer, E. G., McGeer, P. L. (2001) Relationship between beta amyloid peptide generating molecules and neprilysin in Alzheimer disease and normal brain. Brain Res. 919, 115–121.
Yasojima, K., Akiyama, H., McGeer, E. G., McGeer, P. L. (2001) Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of β-amyloid peptide. Neurosci. Lett. 297, 97–100.
Acknowledgements
This work was supported by OTKA (T030339), ETT (T-11/011/2000) and a Széchenyi Professorship to P.K.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
About this article
Cite this article
Papp, H., Török, I., Matsumoto, A. et al. Expression and Distribution of Carboxypeptidase B in the Hippocampal Subregions of Normal and Alzheimer’s Disease Brain. BIOLOGIA FUTURA 54, 55–62 (2003). https://doi.org/10.1556/ABiol.54.2003.1.6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1556/ABiol.54.2003.1.6